<?xml version="1.0" encoding="UTF-8"?>
<document id="30469315">
	<sentence id="s1" text="However, there is limited knowledge on the selenoprotein expression in colorectal adenoma (RNA splicing) and colorectal cancer (CRC) patients, or the interaction with Se status levels.">
		<entity id="s1.e1" charOffset="91-103"
			type="GO" text="RNA splicing" ontology_id="GO_0008380"/>
		<entity id="s1.e2" charOffset="120-126"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="iGPX2/i and liTXNRD3/i showed a higher expression and liGPX3/i, liselenium compound metabolic process/i, liSELENOS/i, and liSEPHS2/i exhibited a lower expression in the disease tissue from adenomas and both cancer groups (lip/i-values from 0.023 to AAAA0.001).">
		<entity id="s2.e1" charOffset="77-112"
			type="GO" text="selenium compound metabolic process" ontology_id="GO_0001887"/>
		<entity id="s2.e2" charOffset="226-232"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="While there were no significant correlations with both Se status markers, liSELENOF/i, liSELENOK/i, and liTXNRD1/i tumor tissue expression positively correlated with Se, while liTXNRD2/i and liTXNRD3/i negatively correlated with liselenium compound metabolic process/i.">
		<entity id="s3.e1" charOffset="124-129"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="247-282"
			type="GO" text="selenium compound metabolic process" ontology_id="GO_0001887"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>